Updated Jul 16, 2026
Sun Elaine D has filed 1 SEC Form 4 filing across 1 company in the last 90 days.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-22 | RXRX | RECURSION PHARMACEUTICALS, INC. | A — Grant or award | 88.4K | $0.00 | |
| 2026-02-10 | DVAX | DYNAVAX TECHNOLOGIES CORP | D — Derivative transaction | 29.9K | — | |
| 2025-06-11 | DVAX | DYNAVAX TECHNOLOGIES CORP | A — Grant or award | 5.8K | $0.00 |
Sun Elaine D is a corporate insider — currently tracked as Director of RECURSION PHARMACEUTICALS, INC. (RXRX). InsiderAlpha tracks every SEC Form 4 filing in real time.
1 primary Form 4 filings in the last 90 days, covering 1 company.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Sun Elaine D profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.